openPR Logo
Press release

Nano-silicon Drug Delivery Platform Market Development Trends And Major Key Players

01-18-2019 03:53 PM CET | Health & Medicine

Press release from: Coherent Market Insights - Pharmaceutical Industry

Nano-silicon Drug Delivery Platform

Nano-silicon Drug Delivery Platform

Safe and effective drug delivery is a major challenge against the pharmaceutical and biotechnology companies. Companies formulate their drugs in various dosage forms such as capsules, powders, inhalers, liquid, drops, tablets, transdermal patches, depot injection, and gels to address the drug delivery challenges in different conditions. Moreover, advancement in research has enabled controlled and sustained release of drugs to decrease the dosage and provide long term effect of the drug. Furthermore, new technologies such as nanotechnology and antibody-drug conjugate are being introduced to minimize cost and increase bioavailability. In all, there is all-together a new wave of innovation in life science sector that delivers medicines at the targeted site in right dose.

Nanotechnology-based platforms are gaining significant importance in research and product development due to the enormous benefits they offer in terms of drug stability, bioavailability, dosage, and shelf-life. Various types of nano-carriers or nanoparticles such as liposomes, magnetic particle, dendrimers, silver nanoparticle, silica nanoparticle, and polymeric micelles, carbon nanoparticles and drug-conjugate nanoparticles are used in different industries to cater the exact need or product.

Download the PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/45

SiSafe Nano-silicon Drug Delivery Platform

SiSaf’s new drug delivery technology called SiSafe is a patented elemental nano-silicon porous structure with a massive surface area. A higher surface area provides high drug-loading capacity and thus significant increase in bioavailability of even the most hydrophobic compounds. So, a less soluble drug that needs to be injected directly in the bloodstream can have enhanced solubility through SiSafe nano-silicon platform. Molecules are incorporated within the nanopores, thus stabilizing the instable molecules and increasing the bioavailability of the drug. SiSafe is a biodegradable technology which enables customizing the rate of onset and release by altering the physical factors of the carriers such as linkage method, porosity, particle size, and pore width.

Potential Applications

SiSafe will be of significant use to pharmaceutical, animal health, biotech and cosmeceutical companies to formulate and package drugs that are difficult to formulate otherwise. Companies finding better solutions for their existing drugs can incorporate this technology to improve their product quality. Also, new drugs used for chronic diseases can be delivered at a low dose to the target sites with the nano-silicon drug delivery platform.

This new nanotechnology-based drug delivery platform offers competitive advantages such as improved safety, efficacy, controlled release and desired time of onset of drug release. After years of research and development, and extensive capital investment, SiSafe nano-silicon drug delivery platform is ready for commercialization. SiSaf is looking to partner with drug developers who desire to improve their formulation with controlled releases and lower doses. SiSaf received a funding of USD 4.9 million from Singapore’s Vickers Venture Partners and Exen Capital recently in November 2016. This partnership is anticipated to be of great aid for SiSaf to reach more markets globally.

Nano-silicon Drug Delivery Platform to enable Low Cost Drug Delivery

Research for the use of nano-silicon particles in targeted tumor therapy is under progress. The study being conducted by various organizations globally including Tel Aviv University, Technion – Israel Institute of Technology in collaboration with Massachusetts Institute of Technology (MIT) and the Harvard Medical School are of the opinion that nano-silicon particles could deliver drugs over a long period of time, may be for weeks or even months. Such advancement in drug delivery technologies will revolutionize the pharmaceutical and biopharmaceutical drug industry by offering targeted drug therapies at a low cost.

Get Discount On This Report:
https://www.coherentmarketinsights.com/insight/request-discount/45

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Nano-silicon Drug Delivery Platform Market Development Trends And Major Key Players here

News-ID: 1513396 • Views: 336

More Releases from Coherent Market Insights - Pharmaceutical Industry

Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 20 …
Coherent Market Insights released a new market study on 2018-2026 Radiopharmaceuticals Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Ask For Sample Copy of Research
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2 …
Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development. Ask For a Sample Copy of This Business Report @
Cannabis Testing Services Market: New Business Opportunities and Investment Rese …
Cannabis market is highly influenced by rigorous legalization efforts, which are aiming for approval of cannabis for medicinal or recreational purpose. Various governments and regulatory authorities are taking efforts to legalize cannabis, owing to its medicinal benefits. Moreover, commercialization of cannabis-based products under the legalized standards require successful cannabis testing, which further results in lucrative growth opportunity for market players. Ask For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/2976 Market
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insigni …
Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around

All 5 Releases


More Releases for SiSaf

Nano-silicon Drug Delivery Platform Market Global Size, Share, Industry Growth, …
Safe and effective drug delivery is a major challenge against the pharmaceutical and biotechnology companies. Companies formulate their drugs in various dosage forms such as capsules, powders, inhalers, liquid, drops, tablets, transdermal patches, depot injection, and gels to address the drug delivery challenges in different conditions. Moreover, advancement in research has enabled controlled and sustained release of drugs to decrease the dosage and provide long term effect of the drug.
Nano-silicon Drug Delivery Platform Market - Rapidly Adopting New Technologies
Safe and effective drug delivery is a major challenge against the pharmaceutical and biotechnology companies. Companies formulate their drugs in various dosage forms such as capsules, powders, inhalers, liquid, drops, tablets, transdermal patches, depot injection, and gels to address the drug delivery challenges in different conditions. Moreover, advancement in research has enabled controlled and sustained release of drugs to decrease the dosage and provide long term effect of the drug.
Nano-silicon Drug Delivery Platform Market Latest Advancements & Outlook to 2026
Research for the use of nano-silicon particles in targeted tumor therapy is under progress. The study being conducted by various organizations globally including Tel Aviv University, Technion – Israel Institute of Technology in collaboration with Massachusetts Institute of Technology (MIT) and the Harvard Medical School are of the opinion that nano-silicon particles could deliver drugs over a long period of time, may be for weeks or even months. Such advancement
Nano-silicon Drug Delivery Platform Market -Industry Insights, and Opportunity 2 …
Research for the use of nano-silicon particles in targeted tumor therapy is under progress. The study being conducted by various organizations globally including Tel Aviv University, Technion – Israel Institute of Technology in collaboration with Massachusetts Institute of Technology (MIT) and the Harvard Medical School are of the opinion that nano-silicon particles could deliver drugs over a long period of time, may be for weeks or even months. Such advancement
Nano-silicon Drug Delivery Platform Market to enable Low Cost Drug Delivery By 2 …
Research for the use of nano-silicon particles in targeted tumor therapy is under progress. The study being conducted by various organizations globally including Tel Aviv University, Technion – Israel Institute of Technology in collaboration with Massachusetts Institute of Technology (MIT) and the Harvard Medical School are of the opinion that nano-silicon particles could deliver drugs over a long period of time, may be for weeks or even months. Such advancement
Nano-silicon Drug Delivery Platform to enable Low Cost Drug Delivery
Research for the use of nano-silicon particles in targeted tumor therapy is under progress. The study being conducted by various organizations globally including Tel Aviv University, Technion – Israel Institute of Technology in collaboration with Massachusetts Institute of Technology (MIT) and the Harvard Medical School are of the opinion that nano-silicon particles could deliver drugs over a long period of time, may be for weeks or even months. Such advancement